Supplemental methods ("Guselkumab and risankizumab for psoriasis: a 44-week indirect real life comparison ")Published: 12-01-2021| Version 1 | DOI: 10.17632/9by92fmdsx.1Contributors:Angelo Ruggiero,Gabriella Fabrocini,Eleonora Cinelli,Matteo MegnaDescriptionSupplemental methodsDownload All Files